| Value | ₹12,402 Cr |
|---|
NSE filing, NSE: BLUESTARCO. Summary written from the filing by ALFA Finder's alert engine.
Blue Star Ltd: key numbers
- Share price
- ₹1,673.00
- Market cap
- ₹34,399 Cr
- Revenue (annual)
- ₹12,402 Cr
- Net profit (annual)
- ₹527.7 Cr
- P/E (TTM)
- 67.5×Sector 42.1×
- Promoter holding
- 36.50%+0.00% QoQ
- FII holding
- 12.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Blue Star Ltd
All →Blue Star Management Change
Blue Star Ltd appointed Mr Nithianand S and Mr Senthil Thangam as Senior Management Personnel effective November 1, 2026. This is a leadership change disclosed under Regulation 30.
Blue Star Results Update
Blue Star's Q2FY27 consolidated revenue rose 21% to Rs 2,930.95 crore, with operating profit up 10.5%. The press release highlights margin pressure from material cost increases.
Blue Star Q2 FY27 Results: Net Profit ₹123.9 Cr, Up 25.4% YoY
Blue Star Ltd reported revenue from operations of ₹2,931 Cr (+21.0% YoY) and net profit of ₹123.9 Cr (+25.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹123.9 Cr · +25.4% YoY
Blue Star Annual General Meeting
Blue Star Ltd declared the voting results of its postal ballot, announcing the appointment of Mr. Nikhilesh Panchal as an Independent Director of the company.
Blue Star Merger & Restructuring
Blue Star Ltd has initiated the voluntary strike-off of its step-down subsidiary, Blue Star Air Conditioning & Refrigeration (U) Limited, which has not commenced business operations.
Blue Star Other Announcement
Blue Star Limited has filed the certificate from its Registrar and Share Transfer Agent confirming compliance with Regulation 74(5) of SEBI (DP) Regulations, 2018.
Other results update announcements
All →Indostar Capital Finance Results Update
IndoStar reported Q2 FY27 standalone results, with disbursements up 51% YoY to ₹1,399 crore. Profit after tax rose to ₹13.1 crore and AUM reached ₹8,459 crore.
Alivus Life Sciences Results Update
Alivus Life Sciences reported Q2FY27 revenue of Rs. 6,820 Mn (up 16.0% YoY) and PAT of Rs. 1,968 Mn in a press release. Investors see record EBITDA margins of 41.8% and capex progress at Solapur and Taloja.
Asset Reconstruction Company (India) Results Update
ARCIL's H1FY27 release shows total income up 48% to Rs.516.4 crore and PAT up 54% to Rs.290.0 crore. Investors should view performance over a longer horizon.
Capital Small Finance Bank Results Update
Capital SFB's Q2 FY27 PAT rose 30.7% year-on-year to ₹45.61 crore, while advances grew 23.4%. Asset quality improved, with GNPA at 2.36% and NNPA at 1.12%.
Strides Pharma Science Results Update
Strides Pharma reported Q2FY27 revenue of ₹14,297m, up 17.1% YoY, and EBITDA of ₹2,509m, up 8.4%, in a press release. Reported PAT rose 2.0% to ₹1,341m.
Fiberweb (India) Results Update
Fiberweb India's Q2 FY27 press release shows total income of ₹30.99 crore, up 209.36% quarter-on-quarter. Net profit rose to ₹1.27 crore.